Clinical Trial

Hydroxyephedrine PET/CT in Sympathetic Nervous System Disease

Recruiting
View on ClinicalTrials.gov →
Summary
To evaluate the potential usefulness of 11C/18F-HED positron emission tomography/ computed tomography (PET/CT) for the diagnosis of primary and metastatic lesions in various Tau-related disease patients.
Trial Details
NCT Number NCT06951984
Lead Sponsor Tianjin Medical University
Collaborators: Tianjin Medical University General Hospital
Conditions Sympathetic Nervous System Diseases, Sympathetic Nervous Structure Injury, Sympathetic Nerve Injury
Enrollment 500 participants
Start Date 2013-03-01
Primary Completion 2028-03-01 (estimated)
Study Completion 2028-03-01 (estimated)
Updated on ClinicalTrials.gov 2025-04-30